Fox Chase Cancer Center clinical trial pipeline

7 trials changed in the last 30 days: 1 stopped, 5 with notable changes, 1 with a minor change only.

1. Stopped

   Gamitrinib Administered Intravenously to · Advanced Cancer

   Recruitment suspended

   Sponsor's reason: Pending amendment to open further Cohorts

   Also in this update: Primary completion pushed from Jun 30, 2026 to Jun 30, 2027; Study completion pushed from Dec 30, 2026 to Dec 30, 2027

   Fox Chase Cancer Center·Phase 1· NCT04827810· Registry history of NCT04827810 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

2. Notable

   Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for…Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

   Primary completion pushed from May 2026 to May 2027

   Fox Chase Cancer Center·Phase 2· NCT04506554· Registry history of NCT04506554 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

3. Notable

   Neratinib and Fam-Trastuzumab Deruxtecan in Advanced…Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

   Primary completion pushed from Jun 2026 to Jun 2027

   Also in this update: Study completion pushed from Jun 2027 to Jun 2028

   Fox Chase Cancer Center·Phase 1· NCT05274048· Registry history of NCT05274048 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

4. Notable

   Understanding the Preferences and Views of Older Adults on the Use…Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning

   Primary completion pushed from Aug 2026 to Mar 2027

   Also in this update: Study completion pushed from Nov 2026 to May 2027

   Fox Chase Cancer Center·Not applicable· NCT06652347· Registry history of NCT06652347 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

5. Notable

   Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis…Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy

   Recruitment opened

   Fox Chase Cancer Center·Phase 2· NCT07663422· Registry history of NCT07663422 on ClinicalTrials.gov (opens the registry)

   Updated Sep 17, 2026

6. Notable

   Prehabilitation in High-risk Oncologic Surgery

   Recruitment opened

   Fox Chase Cancer Center·Not applicable· NCT07638410· Registry history of NCT07638410 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.